What is lipomatosis of the perirenal fat?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 5, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Lipomatosis of the Perirenal Fat: Definition, Diagnosis, and Management

Lipomatosis of the perirenal fat, also known as renal replacement lipomatosis, is a rare condition characterized by excessive proliferation of fatty tissue that replaces the renal parenchyma, typically following severe atrophy or destruction of kidney tissue.

Definition and Pathophysiology

  • Renal replacement lipomatosis involves the proliferation of fibrofatty tissue that replaces normal renal parenchyma, usually unilaterally 1
  • The condition represents an end-stage process where kidney tissue is progressively replaced by fatty infiltration in the renal sinus, hilum, and perirenal spaces 2
  • In severe cases, the entire renal parenchyma may be replaced by fat, hence the term "total renal replacement lipomatosis" 1

Etiology

  • Most cases (>75%) are associated with chronic kidney inflammation, typically due to chronic calculous disease 3
  • Other causes include:
    • Long-standing chronic inflammation or urinary tract infection 4
    • Renal atrophy from various causes 4
    • Aging-related changes 4
    • Post-transplantation changes (rare) 4
  • Some cases are idiopathic, with no identifiable cause 5

Clinical Presentation

  • Often asymptomatic and discovered incidentally on imaging 5
  • May present as a renal mass clinically, mimicking other conditions 5
  • Can be associated with symptoms of the underlying cause (e.g., renal stones, infection)
  • Rarely causes spontaneous bleeding, unlike angiomyolipomas 6

Diagnosis

Imaging Characteristics

  • CT scan: Most accurate for diagnosis, showing:

    • Low-density fatty tissue replacing renal parenchyma 5
    • Nodular masses of adipose tissue within kidney tissue 5
    • Possible coexisting calculi or signs of chronic infection 2
  • MRI: Provides multiparametric assessment that can help characterize the fatty tissue 6

    • Preferred in younger patients to avoid radiation exposure 6
    • Useful for differentiating from other fat-containing renal lesions
  • Ultrasound: May suggest the diagnosis but is less specific 2

    • Typically shows hyperechoic areas corresponding to fatty tissue 6
    • Limited in patients with large body habitus 6

Differential Diagnosis

  • Angiomyolipoma (AML): Contains fat but also vascular elements and smooth muscle 5

    • Unlike lipomatosis, AMLs have fragile vessels that can bleed spontaneously 6
    • AMLs typically appear as discrete masses rather than diffuse replacement 6
  • Lipoma: Benign fatty tumor without the replacement pattern 5

  • Xanthogranulomatous pyelonephritis: Inflammatory condition that can coexist with lipomatosis 2

  • Renal cell carcinoma: Critical to exclude, especially with fat-poor lesions 6

Management

  • Treatment is generally conservative if asymptomatic and diagnosis is certain 3

  • Surgical intervention may be considered when:

    • Diagnosis is uncertain and malignancy cannot be excluded 5
    • Complications from the underlying cause (e.g., recurrent infections, pain) 1
    • Symptomatic presentation requiring intervention 3
  • Nephrectomy may be performed in cases of non-functioning kidney with complete replacement 1

  • Follow-up imaging is recommended to monitor progression, using the same imaging modality for consistency 6

Clinical Pearls and Pitfalls

  • Important distinction: Unlike angiomyolipomas, renal replacement lipomatosis rarely causes spontaneous bleeding as it lacks the abnormal vasculature characteristic of AMLs 6

  • Diagnostic challenge: May be mistaken for other fat-containing renal lesions, particularly angiomyolipomas or renal cell carcinomas with fatty components 5

  • Progressive nature: The condition typically develops over years, with gradual replacement of kidney tissue by fat 3

  • Biopsy considerations: Generally not required if imaging is characteristic, but may be necessary to exclude malignancy in uncertain cases 6

  • Awareness is key: The condition is often missed or misdiagnosed due to its rarity and similarity to other conditions 5

References

Research

Total renal replacement lipomatosis.

International journal of surgery (London, England), 2010

Research

Idiopathic renal replacement lipomatosis: a case report and review of literature.

Indian journal of pathology & microbiology, 2009

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.